Norris Medicines Limited (BOM:524414)
India flag India · Delayed Price · Currency is INR
17.25
+0.17 (1.00%)
At close: Jul 7, 2025

Norris Medicines Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Jul '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
17916813610535065
Upgrade
Market Cap Growth
23.38%23.38%30.14%-70.10%437.69%131.32%
Upgrade
Enterprise Value
395383351319550241
Upgrade
Last Close Price
17.9116.7813.6010.4534.956.50
Upgrade
PS Ratio
3.082.882.411.253.700.53
Upgrade
PB Ratio
-1.20-1.13-1.00-0.84-3.27-0.87
Upgrade
P/FCF Ratio
64.0860.0480.658.94-6.34
Upgrade
P/OCF Ratio
60.0056.2280.118.71-5.84
Upgrade
EV/Sales Ratio
6.786.596.233.825.831.96
Upgrade
EV/EBITDA Ratio
---34.52--
Upgrade
EV/EBIT Ratio
---108.08--
Upgrade
EV/FCF Ratio
141.15137.19208.2427.30-23.46
Upgrade
Debt / Equity Ratio
-1.45-1.45-1.58-1.72-1.97-2.47
Upgrade
Debt / EBITDA Ratio
---23.13--
Upgrade
Debt / FCF Ratio
77.2177.21127.6318.30-17.93
Upgrade
Asset Turnover
0.420.420.400.600.560.61
Upgrade
Inventory Turnover
0.820.820.721.251.481.91
Upgrade
Quick Ratio
0.140.140.120.140.160.16
Upgrade
Current Ratio
0.630.630.670.640.630.70
Upgrade
Return on Assets (ROA)
-3.57%-3.57%-3.36%1.32%-2.65%-7.46%
Upgrade
Return on Capital (ROIC)
-6.84%-6.84%-5.56%1.91%-4.22%-11.40%
Upgrade
Return on Capital Employed (ROCE)
---4.90%--
Upgrade
Earnings Yield
-6.91%-7.37%-8.72%-16.74%-9.34%-76.33%
Upgrade
FCF Yield
1.56%1.67%1.24%11.19%-3.05%15.78%
Upgrade
Buyback Yield / Dilution
0.21%0.21%----
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.